+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infertility Treatment Market by Product, Procedure, Patient type, End User - Global Forecast 2025-2030- Product Image
Infertility Treatment Market by Product, Procedure, Patient type, End User - Global Forecast 2025-2030- Product Image
Sale

Infertility Treatment Market by Product, Procedure, Patient type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5533339
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Infertility Treatment Market grew from USD 5.35 billion in 2023 to USD 5.93 billion in 2024. It is expected to continue growing at a CAGR of 11.26%, reaching USD 11.30 billion by 2030.

Infertility treatment encompasses a range of medical interventions and technologies designed to aid individuals and couples in achieving pregnancy. This field includes procedures such as in vitro fertilization (IVF), artificial insemination, fertility drugs, and surgical interventions. The necessity for infertility treatments arises from various factors, such as age-related fertility decline, lifestyle factors, medical conditions, and unexplained infertility. These treatments are applied in hospitals, fertility clinics, and research institutes to cater to end-users such as couples trying to conceive, single parents, and same-sex couples.

The market for infertility treatment is influenced by factors such as the increasing prevalence of infertility issues, technological advancements, rising awareness, and supportive government initiatives. Moreover, an aging population and lifestyle changes like delayed marriages and childbearing contribute to the market's growth. The Asia-Pacific region, in particular, offers significant growth opportunities due to its large population base and improving healthcare infrastructure. However, the high cost of treatment and limited awareness in underdeveloped regions can pose challenges. Regulatory and ethical considerations are also significant limitations that may affect market expansion.

Innovative research areas include developing minimally invasive procedures and enhancing the success rates of existing treatments through personalized medicine and genetic screening. There is also potential in integrating artificial intelligence to improve diagnostic accuracy and treatment outcomes. Businesses should focus on expanding accessibility and affordability of treatments to tap into unserved markets, particularly in developing countries where healthcare awareness is rising. Furthermore, forging partnerships with insurance companies to provide coverage for infertility treatments could significantly enlarge the consumer base. To sustain growth, companies must navigate cultural and ethical considerations in diverse markets, focusing on patient-centric solutions and elevating the societal discourse on infertility to reduce the associated stigma.

Understanding Market Dynamics in the Infertility Treatment Market

The Infertility Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising number of infrastructure projects all over the world
    • Potential demand for electrical conduit owing to reliability and durability
    • Rapid extension of smart grid networks
  • Market Restraints
    • Concern associated with raw material voltality
  • Market Opportunities
    • Proliferation of electricity usage attributed to digitalization
    • Ongoing refurbishment and retrofit activities in grid infrastructure
  • Market Challenges
    • Difficulty in installation process coupled with hard to find defects in wiring

Exploring Porter’s Five Forces for the Infertility Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Infertility Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Infertility Treatment Market

External macro-environmental factors deeply influence the performance of the Infertility Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Infertility Treatment Market

The Infertility Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Infertility Treatment Market

The Infertility Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Infertility Treatment Market

The Infertility Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infertility Treatment Market, highlighting leading vendors and their innovative profiles. These include ABB Limited, Aliaxis Group S.A., ANAMET Electrical, Inc., Astral PolyTechnik Limited, Atkore International Holdings Incorporated, Cantex, Inc., China Lesso Group Holdings Ltd., Dura-line Corporation, Electri-Flex Company, Hellermanntyton group plc, Hubbell Incorporated, Legrand S.A., Nan Ya Plastics Corp., National pipe & plastics, Inc., Orbia Advance Corporation, Schneider Electric SE, Sekisui Chemical Co., Ltd., Thomas & Betts Corporation, Wienerberger AG, and Zekelman Industries Inc..

Market Segmentation & Coverage

This research report categorizes the Infertility Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Accessories
    • Equipment
      • Cryosystems
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Ovum Aspiration Pumps
      • Sperm Analyzer Systems
      • Sperm Separation Devices
    • Media & Consumables
  • Procedure
    • Artificial Insemination
      • Intracervical Insemination
      • Intratubal Insemination
      • Intrauterine Insemination
    • Assisted Reproductive Technology
      • In Vitro Fertilization
        • Gamete Donation
        • Intracytoplasmic Morphologically Selected Sperm Injection
      • Intracytoplasmic Sperm Injection
      • Surrogacy
    • Fertility Surgeries
      • Hysteroscopy
      • Laparoscopy
      • Laparotomy
      • Microsurgical Reconstruction
        • Vasoepididymostomy
        • Vasovasostomy
      • Myomectomy
      • Tubal Ligation Reversal
      • Varicocelectomy
  • Patient type
    • Female Infertility Treatment
    • Male Infertility Treatment
  • End User
    • Cryobanks
    • Fertility Centers
    • Hospitals & Surgical Clinics
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Infertility Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of infrastructure projects all over the world
5.1.1.2. Potential demand for electrical conduit owing to reliability and durability
5.1.1.3. Rapid extension of smart grid networks
5.1.2. Restraints
5.1.2.1. Concern associated with raw material voltality
5.1.3. Opportunities
5.1.3.1. Proliferation of electricity usage attributed to digitalization
5.1.3.2. Ongoing refurbishment and retrofit activities in grid infrastructure
5.1.4. Challenges
5.1.4.1. Difficulty in installation process coupled with hard to find defects in wiring
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Infertility Treatment Market, by Product
6.1. Introduction
6.2. Accessories
6.3. Equipment
6.4.1. Cryosystems
6.4.2. Gas Analyzers
6.4.3. Imaging Systems
6.4.4. Incubators
6.4.5. Laser Systems
6.4.6. Micromanipulator Systems
6.4.7. Microscopes
6.4.8. Ovum Aspiration Pumps
6.4.9. Sperm Analyzer Systems
6.4.10. Sperm Separation Devices
6.4. Media & Consumables
7. Infertility Treatment Market, by Procedure
7.1. Introduction
7.2. Artificial Insemination
7.3.1. Intracervical Insemination
7.3.2. Intratubal Insemination
7.3.3. Intrauterine Insemination
7.3. Assisted Reproductive Technology
7.4.1. In Vitro Fertilization
7.4.2.1. Gamete Donation
7.4.2.2. Intracytoplasmic Morphologically Selected Sperm Injection
7.4.2. Intracytoplasmic Sperm Injection
7.4.3. Surrogacy
7.4. Fertility Surgeries
7.5.1. Hysteroscopy
7.5.2. Laparoscopy
7.5.3. Laparotomy
7.5.4. Microsurgical Reconstruction
7.5.5.1. Vasoepididymostomy
7.5.5.2. Vasovasostomy
7.5.5. Myomectomy
7.5.6. Tubal Ligation Reversal
7.5.7. Varicocelectomy
8. Infertility Treatment Market, by Patient type
8.1. Introduction
8.2. Female Infertility Treatment
8.3. Male Infertility Treatment
9. Infertility Treatment Market, by End User
9.1. Introduction
9.2. Cryobanks
9.3. Fertility Centers
9.4. Hospitals & Surgical Clinics
9.5. Research Institutes
10. Americas Infertility Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Infertility Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Infertility Treatment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. ABB Limited
14.1.2. Aliaxis Group S.A.
14.1.3. ANAMET Electrical, Inc.
14.1.4. Astral PolyTechnik Limited
14.1.5. Atkore International Holdings Incorporated
14.1.6. Cantex, Inc.
14.1.7. China Lesso Group Holdings Ltd.
14.1.8. Dura-line Corporation
14.1.9. Electri-Flex Company
14.1.10. Hellermanntyton group plc
14.1.11. Hubbell Incorporated
14.1.12. Legrand S.A.
14.1.13. Nan Ya Plastics Corp.
14.1.14. National pipe & plastics, Inc.
14.1.15. Orbia Advance Corporation
14.1.16. Schneider Electric SE
14.1.17. Sekisui Chemical Co., Ltd.
14.1.18. Thomas & Betts Corporation
14.1.19. Wienerberger AG
14.1.20. Zekelman Industries Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. INFERTILITY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. INFERTILITY TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INFERTILITY TREATMENT MARKET DYNAMICS
FIGURE 7. INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
FIGURE 10. INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
FIGURE 12. INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. INFERTILITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. INFERTILITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. INFERTILITY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 9. INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 21. INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 23. INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 30. INFERTILITY TREATMENT MARKET SIZE, BY GAMETE DONATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. INFERTILITY TREATMENT MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 36. INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. INFERTILITY TREATMENT MARKET SIZE, BY LAPAROTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 41. INFERTILITY TREATMENT MARKET SIZE, BY VASOEPIDIDYMOSTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. INFERTILITY TREATMENT MARKET SIZE, BY VASOVASOSTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. INFERTILITY TREATMENT MARKET SIZE, BY TUBAL LIGATION REVERSAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 47. INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS & SURGICAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. CANADA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 87. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 88. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. CANADA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 91. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 92. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 93. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 97. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 101. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 102. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 103. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 104. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. CHINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 139. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 140. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 141. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. CHINA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 143. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 144. CHINA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 145. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. CHINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. INDIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 149. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 150. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 151. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. INDIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 153. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 154. INDIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 155. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. INDIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 159. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 169. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 170. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 171. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 173. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 174. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 175. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 181. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 189. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 190. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 191. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 193. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 194. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 199. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 200. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 201. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 203. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 204. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 209. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 210. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 211. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 213. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 214. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 215. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 219. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 220. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 221. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 223. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 224. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 225. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 226. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 229. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 230. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 231. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 233. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 234. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 235. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 236. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 239. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 240. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 241. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 243. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 244. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 245. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 246. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 258. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 260. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 261. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 262. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 264. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 265. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 266. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 267. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 270. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 271. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 272. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 274. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 275. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 276. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 277. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 279. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 280. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 281. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 282. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 283. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 284. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 285. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 286. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 287. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 289. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 290. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 291. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 292. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 294. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 295. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 296. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 297. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 300. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 301. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 302. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 303. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 304. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 305. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 306. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 307. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 309. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 310. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 311. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 312. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 314. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 315. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. ITALY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 319. ITALY INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 320. ITALY INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 321. ITALY INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
TABLE 322. ITALY INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. ITALY INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 324. ITALY INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
TABLE 325. ITALY INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 326. ITALY INFERTILITY TREATME

Companies Mentioned

The leading players in the Infertility Treatment Market, which are profiled in this report, include:
  • ABB Limited
  • Aliaxis Group S.A.
  • ANAMET Electrical, Inc.
  • Astral PolyTechnik Limited
  • Atkore International Holdings Incorporated
  • Cantex, Inc.
  • China Lesso Group Holdings Ltd.
  • Dura-line Corporation
  • Electri-Flex Company
  • Hellermanntyton group plc
  • Hubbell Incorporated
  • Legrand S.A.
  • Nan Ya Plastics Corp.
  • National pipe & plastics, Inc.
  • Orbia Advance Corporation
  • Schneider Electric SE
  • Sekisui Chemical Co., Ltd.
  • Thomas & Betts Corporation
  • Wienerberger AG
  • Zekelman Industries Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.93 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.3 Billion
Compound Annual Growth Rate11.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Infertility Treatment - Global Strategic Business Report - Product Image

Infertility Treatment - Global Strategic Business Report

  • Report
  • 505 Pages
  • Global
From
Infertility Treatment Global Market Report 2024 - Product Image

Infertility Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Fertility Services Market by Service Type, End User, Fertility Treatment, Technology - Global Forecast 2025-2030 - Product Image

Fertility Services Market by Service Type, End User, Fertility Treatment, Technology - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Infertility Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Infertility Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Infertility Drugs - Global Strategic Business Report - Product Image

Infertility Drugs - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From

About the Infertility Drug Market

The Infertility Drug market is a subset of Sexual and Reproductive Health Drugs, which are used to treat a variety of conditions related to fertility, pregnancy, and sexual health. These drugs are used to treat infertility, endometriosis, polycystic ovary syndrome, and other reproductive health issues. They can also be used to induce ovulation, increase sperm count, and improve egg quality. In addition, they can be used to treat hormonal imbalances, which can affect fertility. Infertility drugs are typically prescribed by a doctor and can be taken orally or injected. Commonly prescribed drugs include clomiphene citrate, gonadotropins, and human chorionic gonadotropin. These drugs can be used in combination with other treatments, such as in vitro fertilization (IVF). Companies in the Infertility Drug market include Merck, Bayer, Teva Pharmaceuticals, and Ferring Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.